Diamonds and Dogs
Vertex Pharmaceuticals (VRTX) soars 20% thanks to positive data on their cystic fibrosis treatment. The treatment results showed positive phase 3 results. Vertex plans to file for U.S. and European approval for the combination of their drugs in the third quarter of 2017, with decisions likely in the first half of 2018. Cystic fibrosis is a genetic disease that affects more than 30,000 people in the U.S., according to the Cystic Fibrosis Foundation.
Dave & Busters (PLAY) taking the day off. The restaurateur fell 3% after a nice run up in the last six months following lack luster earnings. The company beat earnings estimates by 4 cents, but in line sales and in line guidance did not please shareholders. Revenues did rise 15.4% to $270.2 million. Comparable store sales growth exceeded the competitive casual dining benchmark for 19 straight quarters. Dave and Busters also reached an important milestone during the quarter as full year sales exceeded $1 billion.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.